Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of health care products. Co.'s reportable segments include: Established Pharmaceutical Products, which includes a line of branded generic pharmaceutical products; Nutritional Products, which includes a line of adult and pediatric nutritional products; Diagnostic Products, which includes diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; and Vascular Products, which includes coronary, endovascular, structural heart, vessel closure and other medical device products. Non-reportable segments include the Diabetes Care and Medical Optics segments.
Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20
minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.